DNTH
Dianthus Therapeutics Inc.
88.10$
+1.0%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 95.5% | 96.4% | 92.4% | 92.8% | 93.8% | 95.1% | 98.7% | 98.9% | 75.1% | 77.1% | |
| 40.1% | 94.7% | 37.1% | 40.3% | 36.0% | 69.3% | 18.5% | 73.8% | 6.1% | 9.6% | |
| 40.1% | 94.7% | 90.6% | 90.2% | 92.1% | 93.2% | 90.8% | 96.8% | 73.6% | 76.1% | |
| 55.1% | – | – | – | – | 0.8% | 6.8% | 0.3% | 0.2% | 0.0% | |
| – | – | – | – | – | 0.1% | 1.0% | – | – | – | |
| – | – | – | – | – | 0.0% | 1.2% | – | – | – | |
| 20.3% | 7.6% | 7.4% | 12.6% | 11.0% | 9.1% | 11.4% | 5.9% | 5.8% | 7.1% | |
| 20.3% | 7.6% | 6.6% | 8.7% | 7.1% | 5.7% | 9.9% | 5.4% | 4.9% | 5.8% | |
| – | – | – | – | – | – | 0.4% | 0.2% | 0.1% | 0.1% | |
| 14.7% | 0.3% | 2.2% | 1.7% | 2.3% | 1.6% | 1.4% | 1.5% | 1.2% | 1.8% | |
| 79.7% | 92.4% | 92.6% | 87.4% | 89.0% | 90.9% | 88.6% | 94.1% | 94.2% | 92.9% | |
| -85.7% | -83.0% | -65.3% | -111.1% | -157.4% | -171.4% | -55.2% | -49.8% | -46.6% | -63.4% | |
| 19.5% | 4.1% | 1.3% | 1.4% | 1.7% | 1.8% | 4.5% | 2.9% | 8.9% | 7.1% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.